I
Ivan Solovic
Researcher at The Catholic University of America
Publications - 58
Citations - 2861
Ivan Solovic is an academic researcher from The Catholic University of America. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 19, co-authored 49 publications receiving 2385 citations.
Papers
More filters
Journal ArticleDOI
Towards tuberculosis elimination: an action framework for low-incidence countries
Knut Lönnroth,Giovanni Battista Migliori,Ibrahim Abubakar,Lia D'Ambrosio,Gerard De Vries,Roland Diel,Paul Douglas,Dennis Falzon,Marc Andre Gaudreau,Delia Goletti,Edilberto R. González Ochoa,Philip A. LoBue,Alberto Matteelli,Howard Njoo,Ivan Solovic,Alistair Story,Tamara Tayeb,Marieke J. van der Werf,Diana Weil,Jean-Pierre Zellweger,Mohamed Abdel Aziz,Mohamed R.M. Al Lawati,Stefano Aliberti,Wouter Arrazola de Oñate,Draurio Barreira,Vineet Bhatia,Francesco Blasi,Amy Bloom,Judith Bruchfeld,Francesco Castelli,Rosella Centis,Daniel Chemtob,Daniela Maria Cirillo,Alberto Colorado,Andrei Dadu,Ulf R Dahle,Laura De Paoli,Hannah Monica Yesudian Dias,Raquel Duarte,Lanfranco Fattorini,Mina Gaga,Haileyesus Getahun,Philippe Glaziou,Lasha Goguadze,Mirtha del Granado,Walter Haas,Asko Järvinen,Geun Yong Kwon,Davide Mosca,Payam Nahid,Nobuyuki Nishikiori,I. Noguer,Joan O'Donnell,Analita Pace-Asciak,Maria Grazia Pompa,Gilda Popescu,Carlos Robalo Cordeiro,Karin Rønning,Morten Ruhwald,Jean-Paul Sculier,Aleksandar Simunovic,Alison Smith-Palmer,Giovanni Sotgiu,Giorgia Sulis,Carlos A. Torres-Duque,Kazunori Umeki,Mukund Uplekar,Catharina Van Weezenbeek,Tuula Vasankari,Robert J. Vitillo,Constantia Voniatis,Maryse Wanlin,Mario C. Raviglione +72 more
TL;DR: An action framework for countries with low tuberculosis (TB) incidence sets out priority interventions required for these countries to progress first towards “pre-elimination” and eventually the elimination of TB as a public health problem.
Journal ArticleDOI
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.
Ulrich Mack,Giovanni Battista Migliori,Martina Sester,Hans L. Rieder,Stefan Ehlers,Delia Goletti,Aik Bossink,Klaus Magdorf,Christoph Hölscher,Beate Kampmann,S. M. Arend,A Detjen,Graham H. Bothamley,Jean-Pierre Zellweger,Heather Milburn,Roland Diel,Pernille Ravn,Frank Cobelens,P J Cardona,B Kan,Ivan Solovic,Raquel Duarte,Daniela Maria Cirillo +22 more
TL;DR: The main issue regarding testing is to restrict it to those who are known to be at higher risk of developing tuberculosis and who are willing to accept preventive chemotherapy, and to identify an adaptive immune response against, but not necessarily a latent infection with, M. tuberculosis.
Journal ArticleDOI
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Ivan Solovic,Martina Sester,Juan J. Gomez-Reino,Hans L. Rieder,Stefan Ehlers,Heather Milburn,Beate Kampmann,Bernhard Hellmich,Richard Groves,Stefan Schreiber,Robert S. Wallis,Giovanni Sotgiu,E. H. Scholvinck,Delia Goletti,Jean-Pierre Zellweger,Roland Diel,Loreto Carmona,Filippo Bartalesi,Pernille Ravn,Aik Bossink,Raquel Duarte,Connie Erkens,Julia E Clark,Giovanni Battista Migliori,Christoph Lange +24 more
TL;DR: The TBNET consensus statement as discussed by the authors summarises current knowledge and expert opinions and provides evidence-based recommendations to reduce the TB risk among candidates for TNF antagonist therapy, which significantly reduces the risk of progression to TB.
Journal ArticleDOI
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011.
Ivan Solovic,Jerker Jonsson,Maria Korzeniewska-Kosela,D. I. Chiotan,A. Pace-Asciak,E. Slump,R Rumetshofer,Ibrahim Abubakar,S. Kos,P. Svetina-Sorli,Walter Haas,T Bauer,Andreas Sandgren,M J van der Werf +13 more
TL;DR: In the European Union (EU) 72,334 tuberculosis (TB) cases were notified in 2011, of which 16,116 (22%) had extrapulmonary tuberculosis (EPTB).
Journal ArticleDOI
MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
Giovanni Battista Migliori,Simon Tiberi,Simon Tiberi,Alimuddin Zumla,Eskild Petersen,Jeremiah Chakaya,Jeremiah Chakaya,Christian Wejse,Marcela Muñoz Torrico,Raquel Duarte,Jan-Willem C. Alffenaar,Jan-Willem C. Alffenaar,Jan-Willem C. Alffenaar,H. Simon Schaaf,Ben J. Marais,Daniela Maria Cirillo,Riccardo Alagna,Adrian Rendon,Emanuele Pontali,Alberto Piubello,Jose Figueroa,Gabriella Ferlazzo,Alberto L. García-Basteiro,Alberto L. García-Basteiro,Rosella Centis,Dina Visca,Lia D'Ambrosio,Giovanni Sotgiu,T. Abu Arkub,Onno W. Akkerman,Alena Aleksa,Evgeny Belilovski,Enrique Bernal,F-X. Blanc,Martin J. Boeree,Sergey Borisov,Judith Bruchfeld,J. Cadiñanos Loidi,Jose A. Caminero,Anna Cristina Calçada Carvalho,J.J. Cebrian Gallardo,Charalampos,Edvardas Danila,L. Davies Forsman,Justin T Denholm,Keertan Dheda,Roland Diel,Saulius Diktanas,Claudia C. Dobler,Martin Enwerem,Susanna Esposito,N. Escobar Salinas,Alex Filippov,B. Formenti,J.M. García García,Delia Goletti,R. Gomez Rosso,Gina Gualano,Petros Isaakidis,Anna Kaluzhenina,S. Koirala,Liga Kuksa,Heinke Kunst,Yang Li,Cecile Magis-Escurra,Vinicio Manfrin,Selene Manga,Katerina Manika,Valentina Marchese,E. Martínez Robles,Andrey Maryandyshev,Alberto Matteelli,Alessandro Wasum Mariani,Jesica Mazza-Stalder,Fernanda Carvalho de Queiroz Mello,L. Mendoza,A. Mesi,Skaidrius Miliauskas,H. Mustafa Hamdan,Norbert Ndjeka,M. Nieto Marcos,Tom H. M. Ottenhoff,Domingo Palmero,Fabrizio Palmieri,Apostolos Papavasileiou,Marie-Christine Payen,Agostina Pontarelli,M. Pretti Dalcolmo,S. Quirós Fernandez,R. Romero,D. Rossato Silva,A.P. Santos,Barbara Seaworth,M. Sinitsyn,Alena Skrahina,Ivan Solovic,Antonio Spanevello,Marina Tadolini,C. Torres,Zarir F Udwadia,M. van den Boom,Grigory V. Volchenkov,Askar Yedilbayev,R. Zaleskis,Jean-Pierre Zellweger +104 more
TL;DR: The review comprehensively describes the latest information on contact tracing and LTBI management in MDR-TB contacts, while providing guidance on post-treatment functional evaluation and rehabilitation of TB sequelae, infection control and other public health priorities.